Toshinori Nakayama Selected Research

Toshinori Nakayama Research Topics

Disease

49	Inflammation (Inflammations) 12/2023 - 08/2002
35	Neoplasms (Cancer) 01/2023 - 03/2002
23	Asthma (Bronchial Asthma) 01/2022 - 05/2003
11	Infections 11/2018 - 01/2002
8	Pneumonia (Pneumonitis) 01/2019 - 10/2011
7	Lung Neoplasms (Lung Cancer) 10/2012 - 09/2004
6	Hypersensitivity (Allergy) 12/2021 - 11/2002
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 09/2004
6	Glomerulonephritis 10/2013 - 01/2007
5	Vasculitis (Vasculitides) 12/2023 - 06/2014
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 12/2023 - 09/2011
4	Fibrosis (Cirrhosis) 01/2022 - 10/2011
4	Squamous Cell Carcinoma of Head and Neck 03/2016 - 06/2009
4	Human Influenza (Influenza) 03/2014 - 10/2010
4	Colitis 07/2013 - 03/2003
3	COVID-19 04/2024 - 12/2021
3	Seasonal Allergic Rhinitis (Hay Fever) 10/2022 - 01/2010
3	Lung Diseases (Lung Disease) 01/2019 - 02/2006
3	Rhinosinusitis 01/2018 - 02/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2003
3	Contact Dermatitis (Eczema, Contact) 05/2015 - 06/2003
3	Head and Neck Neoplasms (Head and Neck Cancer) 08/2011 - 03/2008
3	Hepatitis 03/2011 - 10/2004
3	Wounds and Injuries (Trauma) 11/2008 - 05/2003
3	Neoplasm Metastasis (Metastasis) 02/2008 - 09/2003
2	Atopic Dermatitis (Atopic Eczema) 07/2023 - 09/2006
2	Immune System Diseases (Immune Disorders) 01/2022 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2021
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 09/2013
2	Starvation 07/2021 - 05/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2017
2	Neuroblastoma 03/2019 - 03/2016
2	Nematode Infections 01/2019 - 08/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 09/2004
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 11/2018 - 01/2017
2	Rheumatoid Arthritis 01/2017 - 09/2013
2	Lung Injury 02/2014 - 10/2011
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2012 - 01/2011
2	Respiratory Hypersensitivity 10/2009 - 08/2002

Drug/Important Bio-Agent (IBA)

36	CytokinesIBA 09/2022 - 05/2003
23	AntigensIBA 10/2022 - 03/2002
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
11	alpha-galactosylceramideIBA 06/2009 - 03/2002
10	Interleukin-5 (Interleukin 5)IBA 07/2023 - 08/2002
10	Peroxidase (Myeloperoxidase)IBA 06/2014 - 01/2007
9	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 01/2007
8	OvalbuminIBA 01/2022 - 02/2006
8	Interleukin-4 (Interleukin 4)IBA 01/2019 - 01/2002
7	AntibodiesIBA 04/2024 - 08/2003
7	AllergensIBA 10/2023 - 05/2003
7	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2010
7	LigandsIBA 05/2021 - 06/2005
7	Interleukin-13IBA 01/2019 - 02/2006
6	Galactosylceramides (Galactocerebrosides)IBA 01/2020 - 11/2010
6	ChemokinesIBA 11/2017 - 01/2007
5	InterferonsIBA 09/2022 - 02/2008
5	GlycolipidsIBA 05/2021 - 10/2004
5	VaccinesIBA 02/2015 - 03/2002
5	Interleukin-6 (Interleukin 6)IBA 02/2014 - 09/2004
5	Macrophage Migration-Inhibitory FactorsIBA 08/2007 - 05/2003
4	EpitopesIBA 04/2024 - 09/2003
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2007
4	Interleukin-33IBA 01/2022 - 02/2015
4	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2022 - 09/2016
4	AmphiregulinIBA 01/2022 - 01/2018
4	Interleukin-12 (IL 12)IBA 03/2019 - 01/2002
4	Messenger RNA (mRNA)IBA 12/2013 - 06/2004
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 12/2023 - 03/2011
3	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2018
3	InterleukinsIBA 03/2019 - 06/2008
3	OsteopontinIBA 01/2019 - 10/2004
3	Immunoglobulin E (IgE)IBA 01/2019 - 01/2003
3	moesinIBA 01/2019 - 10/2013
3	SteroidsIBA 11/2018 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 04/2015 - 08/2008
3	Immunoglobulin G (IgG)IBA 07/2010 - 09/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2008 - 02/2006
3	LipopolysaccharidesIBA 03/2008 - 06/2004
3	Interferon-gamma (Interferon, gamma)IBA 03/2007 - 01/2002
2	Interferon Type IIBA 04/2024 - 01/2022
2	AutoantibodiesIBA 04/2024 - 06/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 10/2022 - 11/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 03/2019
2	Therapeutic UsesIBA 01/2022 - 03/2011
2	GlucocorticoidsIBA 12/2021 - 07/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 08/2015
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2019 - 02/2009
2	ApolipoproteinsIBA 01/2019 - 10/2004
2	Interleukin-1 (Interleukin 1)IBA 01/2019 - 11/2018
2	ResistinIBA 02/2014 - 01/2013
2	HaptensIBA 06/2011 - 03/2003
2	Concanavalin AIBA 03/2011 - 10/2004

Therapy/Procedure

20	Immunotherapy 01/2023 - 11/2002
16	Therapeutics 09/2022 - 05/2003
4	Injections 06/2009 - 10/2004
3	Intra-Arterial Infusions 03/2011 - 06/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018 - 11/2017
2	Intravenous Injections 10/2012 - 02/2008